The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rush, C.
Right arrow Articles by Garside, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rush, C.
Right arrow Articles by Garside, P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2002, 169: 4951-4960.
Copyright © 2002 by The American Association of Immunologists

Efficient Priming of CD4+ and CD8+ T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways1

Catherine Rush2,*,{dagger}, Tim Mitchell* and Paul Garside{dagger}

* Division of Infection and Immunity, Institute of Biomedical and Life Sciences, and {dagger} Western Infirmary, Department of Immunology and Bacteriology, University of Glasgow, Glasgow, United Kingdom

The initial cellular events and interactions that occur following DNA immunization are likely to be key to determining the character and magnitude of the resulting immune response, and as such, a better understanding of these events could ultimately lead to the design of more effective pathogen-appropriate DNA vaccines. Therefore, we have used a variety of sensitive cell-based techniques to study the induction of adaptive immunity in vivo. We examined the efficacy of induction of Ag-specific CD4+ and CD8+ T cell responses in vivo by the adoptive transfer of fluorescently labeled Ag-specific TCR transgenic T cells and have demonstrated how such approaches can be used to study the effect of simple DNA construct manipulations on immunological priming. OVA-specific CD8+ and CD4+ T cells were activated and divided in vivo following immunization with DNA constructs that targeted OVA expression to different subcellular locations; however, the kinetics and degree of cell proliferation were dependent on the cellular location of the expressed protein. DNA vectors encoding cell-associated OVA resulted in greater CD8+ T cell division compared with other forms of OVA. In contrast, soluble secreted OVA targeted to the classical secretory pathway enhanced division of CD4+ T cells. Furthermore, the inclusion of mammalian introns to enhance protein expression increased the ability of poorly immunogenic forms of Ag to activate naive T cells, indicating that not only the location, but also the amount of Ag expression, is important for efficient T cell priming following DNA injection.




This article has been cited by other articles:


Home page
J. Virol.Home page
A.-H. Hovav, M. Santosuosso, M. Bivas-Benita, A. Plair, A. Cheng, M. Elnekave, E. Righi, T. Chen, S. Kashiwagi, M. W. Panas, et al.
X4 Human Immunodeficiency Virus Type 1 gp120 Down-Modulates Expression and Immunogenicity of Codelivered Antigens
J. Virol., November 1, 2009; 83(21): 10941 - 10950.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Gao, J. M. Coulson, A. Whitehouse, and N. Blake
Reduction in RNA Levels Rather than Retardation of Translation Is Responsible for the Inhibition of Major Histocompatibility Complex Class I Antigen Presentation by the Glutamic Acid-Rich Repeat of Herpesvirus Saimiri Open Reading Frame 73
J. Virol., January 1, 2009; 83(1): 273 - 282.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Solvason, Y.-P. Lou, W. Peters, E. Evans, J. Martinez, U. Ramirez, A. Ocampo, R. Yun, S. Ahmad, E. Liu, et al.
Improved Efficacy of a Tolerizing DNA Vaccine for Reversal of Hyperglycemia through Enhancement of Gene Expression and Localization to Intracellular Sites
J. Immunol., December 15, 2008; 181(12): 8298 - 8307.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Kadaoui and B. Corthesy
Secretory IgA Mediates Bacterial Translocation to Dendritic Cells in Mouse Peyer's Patches with Restriction to Mucosal Compartment
J. Immunol., December 1, 2007; 179(11): 7751 - 7757.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Werner-Klein, C. Dresch, P. Marconi, and T. Brocker
Transcriptional Targeting of B Cells for Induction of Peripheral CD8 T Cell Tolerance
J. Immunol., June 15, 2007; 178(12): 7738 - 7746.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. I. M. Loeffler, C. U. Schoen, W. Goebel, and S. Pilgrim
Comparison of Different Live Vaccine Strategies In Vivo for Delivery of Protein Antigen or Antigen-Encoding DNA and mRNA by Virulence-Attenuated Listeria monocytogenes
Infect. Immun., July 1, 2006; 74(7): 3946 - 3957.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Lauterbach, A. Gruber, C. Ried, C. Cheminay, and T. Brocker
Insufficient APC Capacities of Dendritic Cells in Gene Gun-Mediated DNA Vaccination.
J. Immunol., April 15, 2006; 176(8): 4600 - 4607.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. W. Stone, S. Barzee, V. Snarsky, K. Kee, C. A. Spina, X.-F. Yu, and R. S. Kornbluth
Multimeric Soluble CD40 Ligand and GITR Ligand as Adjuvants for Human Immunodeficiency Virus DNA Vaccines
J. Virol., February 15, 2006; 80(4): 1762 - 1772.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Cassataro, S. M. Estein, K. A. Pasquevich, C. A. Velikovsky, S. de la Barrera, R. Bowden, C. A. Fossati, and G. H. Giambartolomei
Vaccination with the Recombinant Brucella Outer Membrane Protein 31 or a Derived 27-Amino-Acid Synthetic Peptide Elicits a CD4+ T Helper 1 Response That Protects against Brucella melitensis Infection
Infect. Immun., December 1, 2005; 73(12): 8079 - 8088.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H.-J. Ko, S.-Y. Ko, Y.-J. Kim, E.-G. Lee, S.-N. Cho, and C.-Y. Kang
Optimization of Codon Usage Enhances the Immunogenicity of a DNA Vaccine Encoding Mycobacterial Antigen Ag85B
Infect. Immun., September 1, 2005; 73(9): 5666 - 5674.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.